Clinical factor | 3-year OS | |||
---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (< 60 vs. ≥ 60 years) | 1.306 (0.775–2.201) | 0.317 | ||
Gender (male vs. female) | 0.717 (0.376–1.368) | 0.312 | ||
HOXD10 (methylation vs. unmethylation) | 1.920 (1.006–3.664) | 0.048* | 1.676 (0.864–3.252) | 0.127 |
HBV infection (yes vs. no) | 0.664 (0.374–1.178) | 0.161 | ||
Liver cirrhosis (yes vs. no) | 0.888 (0.513–1.538) | 0.672 | ||
Tumor size (≤ 5 vs. > 5 cm) | 0.707 (0.412–1.212) | 0.207 | ||
Number of lesions (1 vs. ≥ 1) | 0.770 (0.439–1.349) | 0.361 | ||
Differentiation (well or moderate vs. poor) | 0.787 (0.476–1.301) | 0.351 | 1.267 (0.740–2.172) | 0.388 |
TNM stage (stage I + stage II vs. stage III + stage IV) | 0.391 (0.233–0.656) | 0.000*** | 0.502 (0.279–0.902) | 0.021* |
Lymph node metastasis (negative vs. positive) | 0.431 (0.172–1.075) | 0.071 | ||
Vessel cancerous embolus (negative vs. positive) | 0.356 (0.217–0.584) | 0.000*** | 0.503 (0.287–0.884) | 0.017* |